NASDAQ: TELOTelomir Pharmaceuticals Inc Stock Ownership - Who owns Telomir Pharmaceuticals?
Insider buying vs selling
Have Telomir Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Erez Aminov | CEO and Chairman | 2024-08-19 | 200 | $6.01 | $1.20kSell |
| Erez Aminov | CEO and Chairman | 2024-08-19 | 200 | $6.20 | $1.24kSell |
TELO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TELO insiders and whales buy or sell their stock.
TELO Shareholders
What type of owners hold Telomir Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Shore Trust Bay | 11.06% | 3,292,696 | $8.33M | Insider |
| Vanguard Group Inc | 4.26% | 1,268,754 | $3.21M | Institution |
| Blackrock Inc | 3.55% | 1,056,975 | $2.67M | Institution |
| Christopher C. Chapman Jr. | 3.28% | 975,610 | $2.47M | Insider |
| Craig Eagle | 1.64% | 487,805 | $1.23M | Insider |
| Geode Capital Management LLC | 1.39% | 413,677 | $1.05M | Institution |
| Northern Trust Corp | 0.51% | 151,628 | $383.62k | Institution |
| State Street Corp | 0.39% | 115,794 | $292.96k | Institution |
| Nathen Fuentes | 0.34% | 101,134 | $255.87k | Insider |
| Bank Of New York Mellon Corp | 0.24% | 72,295 | $182.91k | Institution |
TELO vs Biotech Stocks
Telomir Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.